Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2004, Vol. 9 ›› Issue (8): 919-921.

Previous Articles     Next Articles

Inhibition of octreotide on the proliferation of the in vitro cultured liver cancer cell SMMC-7721

LI Chang-Zheng, WANG Zhi-Qiang, FANG Yi1   

  1. Department of Gastroenterology, 1Department of Pharmacological research, General Hospital of Chinese PLA, Beijing 100853, China
  • Received:2004-06-29 Revised:2004-08-09 Online:2004-08-26 Published:2020-11-20

Abstract: AIM: To study the anti-cancer effects of octreotide on the proliferation of liver cancer cells. METHODS: The liver cancer cells SMMC-7721 were cultured in RPMI-1640 media with 10 % fetal bovine serum, 100 U·ml-1 penicillin and streptomycin.10-5 ,10-4, 10-3 and 10-2g·L-1 of octreotide were added and MTT colorimetric assay were used to detect the growth inhibition rate.DNA staining and cell cycle analysis were done at 0, 6, 12, 24 and 36 hours after medication when the concentration of octreotide was 10-3g·L-1.RESULTS: MTT colorimetric tests showed that octreotide suppressed the growth of liver cancer cells.48 hours after medication, the cell growth inhibition rate was 9.33 %, 12.70 %, 19.70 % and 20.93 % when the octreotide concentration was 10-5, 10-4, 10-3 and 10-2g·L-1 separately.Cell cycle analysis showed that the percentage of G0-G1 phase cells increased and the percentage of G2-M phase cells decreased.CONCLUSION: Octreotide inhibits the cultured liver cancer cells proliferation in vitro, its mechanisms may be related to preventing the G0-G1 phase cells from going into G2-M phase.

Key words: octreotide, liver cancer, cell culture, cell proliferation, cell cycle

CLC Number: